Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brovana Added to Tiotropium in COPD
NCT00773786Phase 4Completed
- Sponsor
- Trinity Health
- Start
- Oct 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of arformoterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Trinity Health. Primary endpoints: Forced Expiratory Volume in 1 Second at 1 week and Exercise Treadmill Endurance Time at 1 week. Started Oct 2008; status: completed.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00773786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773786.